Kazushi Shigeno

Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/β-Catenin Signaling Pathway

Shinji Urakami, Hiroaki Shiina, Hideki Enokida et al. · Clinical Cancer Research · 2006 · 183 citations

Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy

Tateki Yoshino, Hiroaki Shiina, Shinji Urakami et al. · Clinical Cancer Research · 2006 · 174 citations

Initial evaluation of prostate cancer with real‐time elastography based on step‐section pathologic analysis after radical prostatectomy: A preliminary study

Masahiro Sumura, Kazushi Shigeno, Taiju Hyuga et al. · International Journal of Urology · 2007 · 90 citations

Clinical Significance of mdm2 and p53 Expression in Bladder Cancer

Hiroaki Shiina, Mikio Igawa, Kazushi Shigeno et al. · Oncology · 1999 · 64 citations

Combination Chemotherapy with Paclitaxel, Estramustine and Carboplatin for Hormone Refractory Prostate Cancer

Shinji Urakami, Mikio Igawa, Nobuyuki Kikuno et al. · The Journal of Urology · 2002 · 62 citations